Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lenka Gibalová"'
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 13; Issue 1; Pages: 369-382
International Journal of Molecular Sciences, Vol 13, Iss 1, Pp 369-382 (2011)
International Journal of Molecular Sciences; Volume 13; Issue 1; Pages: 369-382
International Journal of Molecular Sciences, Vol 13, Iss 1, Pp 369-382 (2011)
The drug efflux activity of P-glycoprotein (P-gp, a product of the mdr1 gene, ABCB1 member of ABC transporter family) represents a mechanism by which tumor cells escape death induced by chemotherapeutics. In this study, we investigated the mechanisms
Autor:
Martina Labudova, Albert Breier, Miroslav Barancik, Lenka Gibalová, Jan Sedlak, Zdena Sulova, Alena Reháková
Publikováno v:
General Physiology and Biophysics. 28:391-403
P-glycoprotein (P-gp, a drug transporter found in the plasma membrane)-mediated multidrug resistance of leukemia cells represents a real obstacle in the effective chemotherapeutic treatment of leukemia. While cisplatin (CisPt) is known to be a substa
Autor:
Uhrík B, Jozef Orlický, Mário Šereš, Roderik Fiala, Lenka Gibalová, Albert Breier, Zdena Sulova, Ima Dovinova
Publikováno v:
Biochemical and Biophysical Research Communications. 335:777-784
L1210/VCR cell line (R) was obtained by adaptation of the L1210 mouse leukaemia cells (S) to vincristine and showed P-glycoprotein (P-gp) mediated multidrug resistance (MDR). R cells were observed to be more sensitive to high external calcium as pare
Autor:
Lucia, Messingerová, Anna, Jonášová, Miroslav, Barančik, Lenka, Poleková, Mário, Šereš, Lenka, Gibalová, Albert, Breier, Zdena, Sulová
Publikováno v:
General physiology and biophysics. 34(4)
A specific type of myelodysplastic syndrome (MDS) is associated with isolated deletion on the long arm of chromosome 5, i.e., 5q-syndrome (del(5q)). The treatment approaches for MDS del(5q) include the immunomodulating drug lenalidomide (LEN). Thirte
Publikováno v:
Anti-cancer agents in medicinal chemistry. 13(1)
Multidrug resistance (MDR) of cancer tissue is a phenomenon in which cancer cells exhibit reduced sensitivity to a large group of unrelated drugs with different mechanisms of pharmacological activity. Mechanisms that reduce cell sensitivity to damage
Autor:
Andrej Rusnak, Jaromir Pastorek, Uhrík B, Albert Breier, Lenka Gibalová, Zdenka Sulová, Martina Labudova, Mário Šereš, Jan Sedlak, Peter Ditte
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 26(3)
Multidrug resistance (MDR) is a phenomenon in which cells become resistant to cytostatic drugs and other substances with diverse chemical structures and cytotoxicity mechanisms. The most often observed molecular mechanism for MDR includes high levels
Autor:
Zdena, Sulová, Peter, Ditte, Tatiana, Kurucová, Eva, Poláková, Kristína, Rogozanová, Lenka, Gibalová, Mário, Seres, Lucia, Skvarková, Ján, Sedlák, Jaromír, Pastorek, Albert, Breier
Publikováno v:
Anticancer research. 30(9)
Overexpression of P-glycoprotein (P-gp), a plasma membrane drug transporter (ABCB1, a member of the ABC transporter family), is the most prevalent cause of multidrug resistance in cancer tissues. Lectin concanavalin A (ConA) induces massive cell deat
Autor:
Zdenka, Sulová, Mário, Seres, Miroslav, Barancík, Lenka, Gibalová, Branislav, Uhrík, Lenka, Poleková, Albert, Breier
Publikováno v:
General physiology and biophysics.
Multidrug resistance (MDR) of neoplastic tissue represents a real obstacle to the effective chemotherapy of cancer. Several mechanisms of MDR were identified, from which the over-expression and efflux activity of P-glycoprotein (P-gp) - a plasma memb
Autor:
Uhrík B, Jan Sedlak, Annamária Kovárová, Zuzana Vajčnerová, Eva Poláková, Albert Breier, Danica Mislovičová, Lenka Gibalová, Zdenka Sulová, Lucia Tylková
Publikováno v:
Journal of proteome research. 8(2)
Multidrug resistance of murine leukemic cell line L1210/VCR (R), obtained by adaptation of parental L1210 cells (S) on vincristine, is associated with overexpression of P glycoprotein (P-gp, the ATP-dependent drug efflux pump). Previously, we found t
Autor:
M. Barancik, A. Jonášová, Mário Šereš, Zdena Sulova, Albert Breier, L. Messingerova, Lenka Gibalová
Publikováno v:
Leukemia Research. 37:S108-S109